AKT1 and metabolic dysfunction-associated steatotic liver disease: The COX-2/EH complex can suppress the PI3K/AKT/mTOR signaling pathway via Sirt1, enhancing autophagy, decelerating hepatocyte senescence, and ameliorating NAFLD.